Prospective Clinical Evaluation of the FilmArray® NGDS Warrior Panel

You may be eligible if

• Whole blood (prospectively collected via informed consent):
• Adult subject has a recorded or self-reported fever within the previous 24 hours
• Subject provides informed consent prior to enrollment and specimen collection
• Subject has not previously provided a whole blood specimen for this study
• Whole blood (residual)
• Whole blood (in EDTA) submitted to laboratory for standard of care testing
• Specimen is not from an individual with a specimen previously enrolled in the study
• Positive Blood Culture:
• Culture was detected as positive by an automated blood culture system
• Culture is not from a patient previously enrolled in the study
• Negative Blood Culture:
• Culture not detected as positive by an automated blood culture system
• Culture is not from a patient previously enrolled in the study
• Sputum:
• Specimen was accepted for testing by the respective site's microbiology laboratory
• Specimen is not from an individual that has a sputum already enrolled in the study